About the Authors
- Ivan M. Munoz
-
Affiliation Medical Research Council Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee, Scotland
- Piotr Szyniarowski
-
Affiliation Medical Research Council Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee, Scotland
- Rachel Toth
-
Affiliation Medical Research Council Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee, Scotland
- John Rouse
-
* E-mail: j.rouse@dundee.ac.uk (JR); c.lachaud@dundee.ac.uk (CL)
Affiliation Medical Research Council Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee, Scotland
- Christophe Lachaud
-
* E-mail: j.rouse@dundee.ac.uk (JR); c.lachaud@dundee.ac.uk (CL)
Affiliation Medical Research Council Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee, Scotland
Competing Interests
Despite acknowledging contributions from “The pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KgaA, Janssen Pharmaceutica and Pfizer) associated with the MRC PPU,” the authors have no competing interests in this paper. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CL. Performed the experiments: IM PS CL. Analyzed the data: CL IM JR. Contributed reagents/materials/analysis tools: RT CL. Wrote the paper: CL JR.